Sponsor:
Rhode Island Hospital
Code:
NCT06439953
Conditions
Post-Op Complication
Spine Surgery
Site Infection
Surgical Site Infection
Spinal Instrumentation
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Chlorhexidine gluconate solution
Vancomycin
Brief summary:
Conditions
Post-Op Complication
Spine Surgery
Site Infection
Surgical Site Infection
Spinal Instrumentation
Study ID
NCT06439953
Start date
Oct 1, 2024
Status verified date
Aug, 2026
Completion date
Apr, 2028
Anticipated
Primary completion date
Apr, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
200 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Prevention
Arms
experimental: Irrisept Irrigation
active comparator: Vancomycin-saline Irrigation
Interventions
Chlorhexidine gluconate solution
Vancomycin
Primary outcome measure
Central contacts
Locations
Rhode Island Hospital
Recruiting
Providence, Rhode Island, United States, 02903
Contacts
Principal Investigator:
Jared S. Fridley, MD
Sponsor
Rhode Island Hospital
Last update posted
Aug 14, 2026
Last verified
Aug, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Rhode Island Hospital on 2026-08-14.